Fresenius (FRE) Morgan Stanley 20th Annual Global Healthcare Conference presentation summary

Company purpose and strategic overview

• Mission is to provide high quality and affordable healthcare, aiming for ever better medicine for more people.

• Operates as a diversified healthcare group with four strong business segments and global presence in over 100 countries.

• Focuses on innovation, quality, and internationalization, with core competencies in hospital supplies, dialysis, and hospital operations.

• Strategy includes improving profitability, driving digital transformation, and prioritizing ESG initiatives.

• Strong financial performance, reliable dividend growth, and sustainable societal contributions are key priorities.

Market position and growth opportunities

• Holds leading positions in non-cyclical, growing healthcare markets, with €37.5bn in 2021 sales and over 300,000 employees.

• Global trends such as rising national income, aging populations, and chronic illness drive demand for healthcare services.

• All segments have excellent market positions and ample growth opportunities, with access to sufficient capital being crucial.

• Strategic imperatives include prioritized capital allocation and broadening the equity base for growth.

ESG and sustainability

• ESG priorities include patient well-being, digital innovation, employee development, diversity, compliance, and environmental management.

• Progress on ESG agenda: CDP Climate rating at B, MSCI at BBB, Sustainalytics at Low Risk; 15% of management incentives linked to ESG KPIs.

• Climate targets: 50% CO2 emissions reduction by 2030, climate neutrality by 2040, with transition to renewable electricity as a priority.